Amgen (AMGN) Market Capitalization (2009 - 2026)

Amgen has reported Market Capitalization for 18 years, with the latest figure at $195.8 billion in Q2 2026.

• On a quarterly basis, Market Capitalization rose 30.25% year-over-year to $195.8 billion in Q2 2026; TTM through Jun 2026 was $195.8 billion, a 30.25% increase from a year earlier, with the FY2025 full-year figure at $176.4 billion, up 26.02% from the prior year.
• Market Capitalization was $195.8 billion for Q2 2026 at Amgen, up from $189.9 billion in the prior quarter.
• The five-year high for Market Capitalization was $195.8 billion in Q2 2026, with the low at $118.8 billion in Q2 2023.
• Average Market Capitalization over 5 years is $151.7 billion, with a median of $151.1 billion recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization surged 41.34% in 2024, then dropped 12.25% in 2025.
• Over 5 years, Market Capitalization stood at $140.2 billion in 2022, then rose by 9.95% to $154.2 billion in 2023, then fell by 9.25% to $139.9 billion in 2024, then advanced by 26.02% to $176.4 billion in 2025, then grew by 11.0% to $195.8 billion in 2026.
• The last three Market Capitalization figures came in at $195.8 billion (Q2 2026), $189.9 billion (Q1 2026), and $176.4 billion (Q4 2025), per Business Quant data.